NCT06026488View on ClinicalTrials.gov

Real-World Study of DLBCL With Different Genetic Subtypes

RecruitingOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
DLBCL - Diffuse Large B Cell LymphomaLymphoma
Interventions
OTHER

Other

real world treatment and survival of DLBCL patients in China

Trial Locations (1)

200025

RECRUITING

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER